Andrew Scaife, the Chief Executive Officer of Quantum Pharma Plc (AIM: QP.), has tendered his resignation as a Director of the Company for family reasons. The Board has commenced a formal search process to secure his replacement as soon as possible. Andrew has agreed to remain as Chief Executive Officer until such time as that appointment is confirmed and to facilitate a smooth handover.
Quantum's Chairman, John Clarke, said: "Andrew has made a significant contribution to the Group during the past seven years and has been instrumental to the Group's growth and strategic direction, and to its admission to AIM in 2014. On behalf of the Board of directors of the Company, I would like to thank Andrew for his contribution and wish him the best for his future career."
Posted by: Quantum Webmaster on 12th July 2016